Prostate Tumors
Neutron therapy is appropriate for the following histologies:
Adenocarcinoma
Sarcoma
Patients who may benefit from neutron therapy include:
Adenocarcinoma patients with poor prognostic factors including
Bulky, stage T2 or T3 tumors
Known tumor in seminal vesicles
Prostate Specific Antigen (PSA) greater than 30
Gleason's score 7 or higher
Pelvic lymph node involvement, biopsy-proven or shown on CT scan
Recurrence after surgery
Adenocarcinoma patients with good prognostic factors
These patients may also benefit from conformal photon therapy, brachytherapy
(seeds), surgery, and/or hormone suppression therapy.
Sarcoma patients with inoperable tumors.
For general questions please contact neutrons@fnal.gov For web questions,
email kroc@fnal.gov Or call 630-840-3865
Danny McCarty - 05 Jan 2004 00:09 GMT
>Subject: advance cancer
>From: "cured?" onmysideagain@hotmail.com
[quoted text clipped - 18 lines]
>(seeds), surgery, and/or hormone suppression therapy.
>Sarcoma patients with inoperable tumors.
Neutrons are absorbed by the nuclei of atoms, changing that atom into an
atom of a different ISOTOPE of the same ELEMENT. That isotope may be STABLE,
in which case the neutron has and will do NOTHING. But there are always
isotopes present whose "next step up" is unstable, so the neutron has, in
effect, "inserted" a radioactive material without the use of surgery. They are
very difficult to aim, however.